author-photo

L. Zhou

Amgen

8

Papers

1563

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

AB0521 Safety, pharmacokinetics, and pharmacodynamics of single doses of a bispecific icosl and baff inhibitor, amg 570, in healthy subjects

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.

2010 Arthritis Care and Research
Show All
- Source
- Cite
- Save
Citations (111)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial†

2008 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (487)
The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis

2007 Clinical and Experimental Rheumatology
Show All
- Source
- Cite
- Save
Citations (130)
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.

2005 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (156)